Yossef Av-Gay (UBC Profsor): Tuberculosis
Contents:
- YOSSEF AV-GAY
- AV-GAY LAB - PRINCIPAL INVESTIGATOR
- AV-GAY, YOSSEF
- PROF. YOSSEF AV-GAY, PHD
- YOSSEF AV-GAY
- AV-GAY LAB INTIFI FECTN-HALTG POUND, BROADLY EFFECTIVE OM COVID-19 TO THE MON LD
YOSSEF AV-GAY
Group Webse Addrs Life Scienc InstuteRoom 25032350 Health Scienc MallVanuver, Brish Columbia V6R 1Z3Canada Visn Statement Dr BSC, MSc, PhD Posn Profsor Divisn Infect Diseas Phone Email * ubc yossef av gay *
Yossef Av-Gay.
AV-GAY LAB - PRINCIPAL INVESTIGATOR
Dr. Yossef Av-Gay is a profsor the Divisn of Infect Diseas the Faculty of Medice. He is also an associate member of the partment of microblogy and immunology and holds an adjunct profsorship at the medil school of Ben Gurn Universy of the Negev, Israel. A microblogist by trag, his rearch terts lie […] * ubc yossef av gay *
Yossef Av-Gay is a profsor the Divisn of Infect Diseas the Faculty of Medice. Av-Gay’s rearch is geared towards the intifitn and characterizatn of novel dgs and dg targets Mybacterium tuberculosis.
Av-Gay’s most signifint disvery was the intifitn and characterizatn of PtpA, a prote phosphatase Mtb which hibs the normal macrophage rponse to fectn.
AV-GAY, YOSSEF
* ubc yossef av gay *
Av-Gay received his BSc Blogy, MSc Microblogy, and PhD Microbial Geics – all om Tel Aviv Universy, Tel Aviv, Israel, and advanced trag at John Inn Instute, Norwich, UK, Albert Este Collage of Medice, New York and UBC partment of Microblogy.
PROF. YOSSEF AV-GAY, PHD
Av-Gay thored over 100 peer review scientific publitns, review articl, book chapters and 15 patents. Av-Gay served as an edor for the Journal of Blogil Chemistry (2010-2015), and on scientific advisory boards of several btechnology pani. Av-Gay is a member of the scientific review panels of the Canadian Instute of Health Rearch (Microblogy and Infect Disease (2009-2016) and Foundatn and Project Grants (2016-), the French Agence Natnale la Recherche, Innovative Medice Innovatns, The UK wele Tst, US Natnal Instute of Health, and the European Commissn FP6, FP7 and Horizon 2020 programs.
Richter A, Strch A, Chao J, Ko M, Av-Gay Y.
Hekel F, Shen L, Richard-Greenblatt M, Gee CL, Gay LM, Okon M, Bui JM, Alber T, Av-Gay Y, Gsponer J and McIntosh LP.
YOSSEF AV-GAY
Laqua K, Klemm M, Richard-Greenblatt M, Richter A, Liebe L, Huang T, L S, Guardia A, Pérez-Herran E, Ballell L, Av-Gay Y, Immg P.
Wong D, Li W, Chao JD, Zhou P, Nala G, Tsui C, Ko M, Xie J, Martez-Frail C, Av-Gay Y.
Tal A, Greenberg D, Av-Gay Y, Golan-Tripto I, Feste Y, Ben-Shimol S, Dagan R, Goldbart AD. Tsui CKM, Wong D, Nala G, Gardy JL, Hsiao WWH, Av-Gay Y. Zheng X, Av-Gay Y.
AV-GAY LAB INTIFI FECTN-HALTG POUND, BROADLY EFFECTIVE OM COVID-19 TO THE MON LD
Margel D, Mizrahi M, Regev-Shoshani G, Ko M, Moshe M, Ozalvo R, Shav-Grievk L, Baniel J, Kedar D, Yossepowch O, Lifshz D, Nadu A, Greenberg D, Av-Gay Y.
Richard-Greenblatt M, Av-Gay Y. Williams DE, Dalisay DS, Chen J, Polishchuck EA, Patrick BO, Nala G, Ko M, Av-Gay Y, Li H, Magarvey N, Anrsen RJ.